![](https://static.scientificamerican.com/sciam/cache/file/D866A87E-EA90-4F44-ADAFC8BCEC75D939_agenda.jpg?w=275&h=154&fit=crop)
Why There’s a Serious Cancer Drug Shortage, and How to Fix It
The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market
The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market
New research in mice suggests that a stem cell involved in backbone development might help tumors from other parts of the body move to the spine
What dermatologists say about sun sensitivity, cancer risk and the products they use for sun protection
United Nations groups say the artificial sweetener poses a possible risk of liver cancer—but there’s no evidence for harm under the current daily limit
A scientist claims elephants’ cancer-preventing genes may have evolved to protect their sperm from the scorching hot habitats the pachyderms’ live in...
Many generic drugs for cancer and ADHD, blood thinners and antibiotics are in short supply, in part because there is little profit in making them
Research shows that disrupting the body’s circadian rhythm raises cancer risk, and resetting it may bring that risk down
For lung cancer patients who have a specific genetic mutation, taking a pill called osimertinib after surgery greatly reduced the risk of lung cancer recurrence
The COVID pandemic put mRNA technology, long in development, to the test. Here’s a look at how it might fight cancer and when it might reach patients
Medical boards and task forces recommend mammogram screenings for breast cancer begin at age 40. But people in high-risk groups may want to consider getting tested even earlier
Ovarian cancer is hard to detect and usually deadly. Preemptively removing fallopian tubes during other abdominal surgeries could save hundreds of thousands of lives
An mRNA vaccine prevented tumor recurrence after surgery in eight of 16 patients, but the therapy still needs to be validated in larger trials
Women with dense breasts are at higher risk of breast cancer and are underdiagnosed, but other factors also play an important role
A federal judge’s ruling that invalidates part of the Affordable Care Act could mean people will have to pay for certain types of preventive care, though likely not immediately
Supersmeller ants quickly learn to recognize tumors’ signatures in mouse urine
The “most complicated therapy ever” tailors bespoke, genome-edited immune cells to attack tumors
As recent advances improve the prospects of detecting and catching lung cancer early, a new challenge arises: how to ensure people worldwide, regardless of their socioeconomic circumstances, benefit from new clinical tools...
Elephants use 20 copies of a key cancer-fighting gene—and humans just have one
Human endogenous retroviruses make up 8 percent of the human genome. Researchers are studying how active they are
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account